Patent · US Active

Anti-HER2 antibody and anti-c-Met/anti-HER2 bispecific antibodies comprising the same

US9975960B2 · kind B2 · utility

2Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2015
Grant dateMay 22, 2018
Priority date
Expiry dateMay 11, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An anti-HER2 antibody, an anti-c-Met/anti-HER2 bispecific antibody including the same, method for preparing same, and a method of preventing and/or treating a cancer using the same are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.